Ground Swell Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ground Swell Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$282K	Buy	+1,754	New	+$270K	0.53%	24

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ground Swell Capital's JAZZ Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2014: 1,754 shares worth $282K. The stake represents 0.53% of the portfolio and ranks #24 among its holdings.

325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

Ground Swell Capital held 1,754 shares of Jazz Pharmaceuticals worth $282K as of Q3 2014.
Jazz Pharmaceuticals was a new Ground Swell Capital position in Q3 2014.
Jazz Pharmaceuticals made up 0.53% of Ground Swell Capital's portfolio in Q3 2014, its #24 holding.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.